BioSpace News Archive

Drug Development

Jazz Pharma Hits the Mark with Another Narcolepsy Treatment

An investigational medicine in late-stage development by Jazz Pharmaceuticals hit the mark in treating cataplexy and excessive daytime sleepiness in adults with narcolepsy.

September 26, 2019
·
3 min read
·
Alex Keown
An AI First: Deep Genomics Platform Reveals Wilson’s Disease Drug Candidate

Brendan Frey, founder and chief executive officer of Deep Genomics, called the discovery an “important milestone” for the company’s drug discovery program, as well as for Wilson’s disease patients.

September 26, 2019
·
3 min read
·
Alex Keown
Could You Start a Life Sciences Business?

Have you dreamed of running your own life sciences business? Doing so is not out of the reach of life sciences professionals. Here are all the possibilities you can choose from.

September 26, 2019
·
4 min read
·
By Katharine Hansen, PhD
Business

New NYC Life Sciences Campus Expected to Provide 1,400 Jobs

New York City’s life sciences community continues to boom as Deerfield Management Company, in partnership with LifeSci NYC and the New York City Economic Development Corporation, announced an initial $635 million investment to create a transformative life sciences campus in the Big Apple.

September 26, 2019
·
2 min read
·
Alex Keown
BioMidwest

Investigational Drug Combined with Checkpoint Inhibitors Shows Promise in Some Cancers

New clinical data shows that Eli Lilly’s investigational oncology drug pegilodecakin, in combination with a checkpoint inhibitor, could be a potential new treatment for patients with non-small cell lung cancer and kidney cancer.

September 26, 2019
·
2 min read
·
Alex Keown
Business

Ergomed plc: Interim results for the six months ended 30 June 2019

Ergomed plc, a company focused on providing specialised services to the global pharmaceutical industry, announces its unaudited interim results for the six months ended 30 June 2019.

September 26, 2019
·
5 min read
FDA

Omnia Medical Receives First Ever 510(k) Clearance for PEEK-Optima HA Enhanced Cervical VBR

US FDA 510(k) clearance paves the way for an innovative orthopedic product that offers the potential to improve bone apposition and, as a consequence, patient outcomes 1-3

September 26, 2019
·
3 min read
FDA

Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults

Bavarian Nordic A/S announced that the U.S. Food and Drug Administration has approved JYNNEOS™ for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.

September 26, 2019
·
9 min read
Biotech Beach

DiaSorin Molecular’s Simplexa™ VZV Swab Direct Molecular Assay Gets CE Mark

DiaSorin Molecular LLC announced that it has received CE marking for its Simplexa™ VZV Swab Direct assay.

September 26, 2019
·
2 min read
Job Trends

GSK and AstraZeneca’s PARP Inhibitors Will Flex Their Muscles at ESMO

PARP inhibitors will be taking center stage at the European Society of Medical Oncology Congress as rival drugmakers aim to show off data that supports broader use of the drug in treating various cancers.

September 26, 2019
·
2 min read
·
Alex Keown